Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xinjiang Medical UniversityActive in the last 2 years

Wei Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-8918-0525; OpenAlex author ID A5121099736. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 5

  1. Bibliometric analysis of pancreatic cancer liver metastasis research: global trends, collaborations, and emerging research hotspots. Last author DOI 10.3389/fonc.2025.1546400↗
  2. Exploring the causal association between inflammatory cytokines and pancreatic cancer: a two-sample Mendelian randomized study Last author DOI 10.21203/rs.3.rs-4569438/v1↗
  3. Retraction notice to "Pancreatic cancer cells-derived exosomal long non-coding RNA CCAT1/microRNA-138-5p/HMGA1 axis promotes tumor angiogenesis" [Life Sci. 278… Co-author DOI 10.1016/j.lfs.2023.121429↗
  4. LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p. Co-author DOI 10.1155/2023/6785005↗
  5. RETRACTED: Pancreatic cancer cells-derived exosomal long non-coding RNA CCAT1/microRNA-138-5p/HMGA1 axis promotes tumor angiogenesis. Co-author DOI 10.1016/j.lfs.2021.119495↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yingjie Huang · 1 shared paper, 2025 · strength 0.42
  2. Kunzeng Len · 2 shared papers, 2021–2023 · strength 0.41
  3. Yingjie Huang · 1 shared paper, 2024 · strength 0.36
  4. Qilong Chen · 1 shared paper, 2023 · strength 0.22
  5. Chouman Sulidankazha · 1 shared paper, 2023 · strength 0.22
  6. Hai Lan Lin · 1 shared paper, 2023 · strength 0.22
  7. Tieying He · 1 shared paper, 2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.